Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/11/2026 | 15,169 | 0.1% | 19,652 | 12/31/2025 |
| 2025 Q2 | 8/1/2025 | 20,712 | 0.2% | 39,452 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 21,089 | 0.3% | 33,252 | 3/31/2025 |
| 2024 Q4 | 2/4/2025 | 21,834 | 0.2% | 30,652 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 32,538 | 0.3% | 30,952 | 9/30/2024 |
| 2024 Q1 | 4/25/2024 | 25,460 | 0.3% | 26,452 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 22,969 | 0.3% | 26,152 | 12/31/2023 |
| 2023 Q3 | 10/23/2023 | 22,098 | 0.3% | 26,852 | 9/30/2023 |
| 2023 Q2 | 8/2/2023 | 19,797 | 0.2% | 27,552 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 22,885 | 0.3% | 27,852 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 20,600 | 0.3% | 28,552 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 22,251 | 0.3% | 37,642 | 9/30/2022 |
| 2022 Q2 | 8/11/2022 | 22,251 | 0.3% | 37,642 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 19,236 | 0.2% | 27,542 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 17,504 | 0.2% | 27,717 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 17,826 | 0.2% | 29,456 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 16,620 | 0.2% | 29,756 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 14,788 | 0.1% | 31,256 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 14,762 | 0.1% | 30,556 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 17,217 | 0.2% | 30,756 | 9/30/2020 |
| 2020 Q2 | 8/13/2020 | 18,058 | 0.2% | 28,956 | 6/30/2020 |
| 2020 Q1 | 5/11/2020 | 10,858 | 0.2% | 22,236 | 3/31/2020 |
| 2019 Q4 | 2/10/2020 | 7,936 | 0.1% | 21,136 | 12/31/2019 |
| 2014 Q1 | 4/24/2014 | 6,701 | 0.1% | 22,316 | 3/31/2014 |
| 2013 Q4 | 1/23/2014 | 5,921 | 0.1% | 21,511 | 12/31/2013 |